Introduction
============

Abnormalities in arterial function contribute to an increased risk of cardiovascular events in obese patients ([@ref-23]). Previous studies have established that obesity is positively correlated with arterial stiffness, which is a key characteristic of atherosclerosis ([@ref-1]; [@ref-29]). Pulse wave velocity (PWV) has been recognized as the most largely employed method to assess arterial stiffness ([@ref-3]). Aortic arterial stiffness is evaluated by carotid-femoral PWV (cfPWV), and systemic arterial stiffness is determined by brachial-ankle PWV (baPWV). These markers are considered to be simple and reliable indicators of conditions of central and systemic arterial function.

A strong link has been identified between obesity and autonomic dysfunction ([@ref-24]). The autonomic nervous system plays a vital role in regulating heart rate and vascular tone ([@ref-14]). Thus, impaired autonomic function may contribute to increased arterial stiffness in obese individuals ([@ref-5]). Furthermore, recent studies have suggested an inverse correlation between autonomic activity and arterial stiffness in patients with type 1 diabetes ([@ref-14]) and systemic sclerosis ([@ref-9]). Although the evidence linking autonomic function and arterial stiffness in healthy and diseased states has been shown, it is still largely unexplored in this area under physiological and pathological conditions ([@ref-2]). Therefore, the elucidation of the association between these cardiovascular biomarkers may provide a new effective therapeutic strategy against cardiovascular disease.

Previous clinical trials have reported that exercise and diet intervention improve the obesity-associated cardiovascular biomarkers of body composition, blood pressure, dyslipidemia, insulin resistance, and inflammation. Additionally, recent studies have demonstrated that exercise or dietary modification may improve cardiac autonomic function ([@ref-4]; [@ref-17]) and arterial stiffness ([@ref-10]; [@ref-19]) in obese subjects. However, there have been few studies focusing on the specific relationship between autonomic function and arterial stiffness under lifestyle modifications of exercise and diet.

Thus, the present study examined the relationship between autonomic function and arterial stiffness in people with obesity after an 8-week program of combined exercise and dietary restriction. We hypothesized that exercise and diet intervention would improve autonomic function associated with decreased arterial stiffness.

Materials and Methods
=====================

The trial forms part of a larger study with lifestyle interventions on obese adults (Effects of exercise training and diet restriction on cardiovascular function in obese population, ISRCTN83594346). Results regarding the relationship between circulating irisin concentrations and endothelial progenitor cell levels in an obese population after exercise and dietary intervention have been reported in an earlier publication ([@ref-13]). In the present paper, we focus solely on the relationship between autonomic function and arterial stiffness under lifestyle modifications of exercise and diet. This study was conducted following the ethical guidelines of the Declaration of Helsinki, and the study was approved by the Ethics Committee of Guangzhou Sport University (approval No. GSU20160012). All participants provided written informed consent prior to the measurements. The study protocol and supporting TREND checklist were provided as [Supplemental Information](#supplemental-information){ref-type="supplementary-material"}; see [S1 Protocol](#supp-3){ref-type="supplementary-material"} and [S1 Checklist](#supp-2){ref-type="supplementary-material"}.

Participants
------------

Obese adults between the ages of 18 and 40 years (body mass index (BMI) ≥ 30 kg/m^2^) were recruited from a weight loss camp after a physical examination. Those with diabetes, unstable angina pectoris, cardiomyopathy, severe lung diseases, or renal failure were excluded. Of the twenty-nine enrolled participants, twenty-two met the criteria for inclusion and were selected for the training program. Seventeen participants (M/F, 11/6) who completed the program and provided valid measurements at both baseline and follow-up were included in the analysis (TREND flow diagram, [Fig. 1](#fig-1){ref-type="fig"}).

![Flow diagram of participants through the research program.](peerj-05-3900-g001){#fig-1}

Exercise and diet intervention
------------------------------

Details for the diet and exercise protocol have been previously described ([@ref-13]). Briefly, subjects were provided with calorie-restricted diets of 1,300--2,200 kcal/day based on their weight. Energy intakes were calculated using the Harris-Benedict equation ([@ref-32]). The targeted daily caloric intake deficit was 500 kcal/day. The diet consisted of balanced proportions of 60% carbohydrate, 20% protein, and 20% fat, and calories were distributed as 30%, 40%, and 30% at breakfast, lunch, and dinner, respectively. The dietitians prepared and supervised all meals. Subjects performed a series of endurance exercises including bicycling, walking, running, dancing, and ball games for 5 h/day. The endurance exercises involved moderate and high intensity training. The intensity of moderate-intensity exercise was set at 70--85% of the subject's maximum heart rate (HRmax), which was calculated with the formula of 208 − (0.7 × *age*). The high-intensity exercise (∼90% of HRmax) was alternated with low-intensity exercise (∼60% of HRmax) during training. Subjects were also supplemented with strength training. After measuring maximal strength, strength exercise was performed at 40--50% maximal strength for 2--3 sets of 12--15 repetitions with 2--3 min rest between each set. Exercise interventions were performed 6 days/week for 8 weeks. A daily training log assessed the subject's compliance was recorded. The exercise training was designed to lead to an energy expenditure of 1,500--2,500 kcal/day and was supervised by qualified trainers. Measurements were performed before the training and 24 h after last session of the 8-week exercise and diet program.

Body composition and biochemical factors
----------------------------------------

Height and weight were determined according to previously described method ([@ref-11]), and BMI was calculated (kg/m^2^). Body composition was assessed by a body composition analyzer (Inbody 370; Biospace, Seoul, Korea). Fasting blood samples were taken in the early morning for the assessment of total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), glucose, and insulin. Insulin resistance was evaluated using the Homeostasis Model of Assessment of Insulin Resistance (HOMA-IR) and was calculated as the \[fasting insulin (µU/ml) × fasting glucose (mmol/L)\]/22.5. Concentration of high-sensitivity C-reactive protein (hsCRP) in serum was analyzed using an ELISA Kit (Cusabio; Biotech. Co., LTD, Wuhan, China) in accordance with the manufacturer's instruction.

Resting heart rate and brachial blood pressure
----------------------------------------------

Resting heart rate (HR) and brachial systolic/diastolic blood pressure (SBP/DBP) were measured three times by a sphygmomanometer. The participants were requested to rest for at least 10 min, and the average of three measurements was taken.

Heart rate variability (HRV)
----------------------------

HRV was measured using the SphygmoCor device (AtCor Medical, Sydney, Australia), following previously described protocols ([@ref-5]; [@ref-14]). As for the time domain analysis, we determined the standard deviation (SD) of normal-to-normal (NN) intervals (SDNN) and square root of the mean squared differences of successive NN intervals (RMSSD). For frequency domain analysis, total power (TP) in the frequency (0--0.40 Hz) was divided into low-frequency power (LF: 0.04--0.15 Hz, modulated mainly by sympathetic system) and high-frequency power (HF: 0.15--0.40 Hz, modulated by parasympathetic system). Normalized units (nu) were calculated by dividing the power of LF or HF by (LF + HF). LF/HF ratio reflects the balance between sympathetic and parasympathetic activity (sympathovagal balance).

Pulse wave velocity
-------------------

cfPWV was measured according to previously described technique ([@ref-16]; [@ref-18]). The transit time of the pulse wave from the left ventricle to the carotid artery (t1) and from the left ventricle to the femoral artery (t2) were measured by a pressure sensitive transducer (tonometer). The distance from the suprasternal notch to the carotid artery (d-carotid) and from the suprasternal notch to the femoral artery (d-femoral) were calculated using a measuring tape. The cfPWV was calculated as the difference in distance between d-femoral and d-carotid divided by the time difference between t1 and t2. Additionally, baPWV and cfPWV were also calculated with an oscillometric device (boso ABI-system 100; BOSCH & SOHN, Germany).

Pulse wave analysis
-------------------

Aortic pressure waveforms were derived using a generalized validated transfer function (SphygmoCor device) ([@ref-6]; [@ref-16]; [@ref-26]). Briefly, the aortic pressure wave is composed of a forward wave, created by ventricular contraction, and a reflected wave that returns to the aorta from the periphery. Augmentation pressure is the difference between the second and first systolic peaks ([@ref-6]). The augmentation index (AIx) was defined as the augmentation pressure expressed as a percentage of the aortic pulse pressure ([@ref-26]). Since AIx is influenced by heart rate, it is normalized to a standard heart rate of 75 beats/min (AIx75).

Statistical analysis
--------------------

Analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Paired-sample t-tests were used to compare the data obtained before and after the intervention. Pearson correlation analysis was performed to measure the association between two variables. Data are reported as mean ± SD. A *P*-value \< 0.05 is used to indicate statistical significance.

Results
=======

Effects of exercise and diet intervention on anthropometric and metabolic parameters
------------------------------------------------------------------------------------

The general outcomes (descriptive characteristics, whole body composition, and metabolic parameters) measured before and after the 8-week training program of obese participants have been previously described in detail ([@ref-13]). As shown in [Table 1](#table-1){ref-type="table"}, in response to the exercise and diet intervention, obese participants (22.1 ± 2.8 years) had significant reductions in body weight, BMI, body fat mass, and body fat percentage (all *P* \< 0.001). Obese subjects also had significantly lower concentrations of serum cholesterol (*P* \< 0.05), triglycerides (*P* \< 0.01), LDL-c (*P* \< 0.05), insulin (*P* \< 0.01), and HOMA-IR (*P* \< 0.01) following intervention. Whereas, no significant changes in levels of blood glucose and HDL-c were found ([Table 1](#table-1){ref-type="table"}). Moreover, the intervention markedly reduced inflammation, as shown by a decline in hsCRP levels (*P* \< 0.01; [Table 1](#table-1){ref-type="table"}).

10.7717/peerj.3900/table-1

###### The anthropometric and metabolic parameters of subjects before and after 8-week combined exercise and diet intervention.

![](peerj-05-3900-g002)

  Parameters                      Before          After
  ------------------------------- --------------- -------------------
  Age (yr)                        22.1 ± 2.8      --
  Gender (*n*) (M/F)              17 (11/6)       --
  Height (cm)                     174.8 ± 1.85    --
  Body weight (kg)                116.6 ± 24.6    103.4 ± 22.4^∗∗∗^
  BMI (kg/m^2^)                   37.8 ± 5.0      33.5 ± 4.4^∗∗∗^
  Body fat (kg)                   47.4 ± 12.7     38.2 ± 12.2^∗∗∗^
  Body fat (%)                    40.9 ± 4.6      36.6 ± 5.9^∗∗∗^
  Cholesterol (mmol/l)            5.35 ± 0.92     4.74 ± 1.34^∗^
  Triglycerides (mmol/l)          2.15 ± 1.08     1.32 ± 0.88^∗∗^
  HDL-c (mmol/l)                  0.99 ± 0.14     0.99 ± 0.22
  LDL-c (mmol/l)                  3.44 ± 0.75     2.99 ± 0.95^∗^
  Fasting blood glucose (mg/dl)   5.61 ± 0.56     5.39 ± 0.57
  Fasting insulin (pmol/l)        200.8 ± 115.8   116.7 ± 81.2^∗∗^
  HOMA-IR                         7.34 ± 4.9      4.08 ± 2.9^∗∗^
  hsCRP (µg/ml)                   2.49 ± 1.71     1.36 ± 1.61^∗∗^

**Notes.**

BMIbody mass indexHDL-chigh-density lipoprotein cholesterolLDL-clow-density lipoprotein cholesterolHOMA-IRHomeostasis Model of Assessment of Insulin ResistancehsCRPhigh-sensitivity C-reactive protein

Values are presented as mean ± SD. ^∗^ *P* \< 0.05, ^∗∗^ *P* \< 0.01, ^∗∗∗^*P* \< 0.001 vs. Before.

Effects of exercise and diet intervention on cardiovascular function
--------------------------------------------------------------------

Using the boso ABI-system 100 device, we observed a reduction after intervention in the right baPWV relative to baseline (9.78 ± 1.25 m/s vs. 9.32 ± 0.88 m/s, *P* \< 0.05). However, no significant difference was observed in the left baPWV ([Table 2](#table-2){ref-type="table"}). Additionally, we found a reduction in cfPWV using both the boso device (5.91 ± 0.98 m/s vs. 5.58 ± 0.59 m/s, *P* \< 0.05) and SphygmoCor device (6.21 ± 1.55 m/s vs. 5.44 ± 1.30 m/s, *P* \< 0.05). Moreover, obese individuals showed significant reductions in augmentation pressure (*P* \< 0.05), AIx75 (*P* \< 0.01), and resting heart rate (*P* \< 0.001) after the intervention ([Table 2](#table-2){ref-type="table"}). There was a significant decrease in brachial SBP (*P* \< 0.001), brachial pulse pressure (*P* \< 0.05), aortic SBP (*P* \< 0.001), and aortic pulse pressure (*P* \< 0.05) following exercise and diet intervention ([Table 2](#table-2){ref-type="table"}). However, there were no changes in brachial and aortic DBP.
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###### The cardiovascular function parameters of subjects before and after 8-week combined exercise and diet intervention.
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  Parameters                                                      Before           After
  --------------------------------------------------------------- ---------------- -------------------
  Left baPWV (m/s)[^a^](#table-2fn3){ref-type="fn"}               9.59 ± 1.28      9.45 ± 0.81
  Right baPWV (m/s)[^a^](#table-2fn3){ref-type="fn"}              9.78 ± 1.25      9.32 ±0.88^∗^
  cfPWV (m/s)[^a^](#table-2fn3){ref-type="fn"}                    5.91 ± 0.98      5.58 ±0.59^∗^
  cfPWV (m/s)[^b^](#table-2fn4){ref-type="fn"}                    6.21 ± 1.55      5.44 ±1.30^∗^
  Augmentation pressure (mmHg)[^b^](#table-2fn4){ref-type="fn"}   2.50 ± 3.16      1.31 ±2.41^∗^
  AIx75 (%)[^b^](#table-2fn4){ref-type="fn"}                      7.50 ± 12.09     −0.25 ±13.49^∗∗^
  HR (bpm)                                                        74 ± 9           61 ±9^∗∗∗^
  bSBP (mmHg)                                                     127.8 ± 11.8     115.3 ±7.4^∗∗∗^
  bDBP (mmHg)                                                     85.2 ± 9.4       79.9 ± 10.8
  bPP (mmHg)                                                      42.6 ± 6.40      35.4 ±9.14^∗^
  aSBP (mmHg)[^b^](#table-2fn4){ref-type="fn"}                    112.81 ± 10.51   102.94 ±8.67^∗∗∗^
  aDBP (mmHg)[^b^](#table-2fn4){ref-type="fn"}                    86.50 ± 10.11    80.75 ± 11.17
  aPP (mmHg)[^b^](#table-2fn4){ref-type="fn"}                     26.50 ± 5.29     22.19 ±5.18^∗^

**Notes.**

baPWVbrachial-ankle pulse wave velocitycfPWVcarotid-femoral pulse wave velocityAIx75augmentation index standardized to a heart rate of 75/minHRheart ratebSBPbrachial systolic blood pressurebDBPbrachial diastolic blood pressurebPPbrachial pulse pressureaSBPaortic systolic blood pressureaDBPaortic diastolic blood pressureaPPaortic pulse pressure

Values are presented as mean ± SD. ^∗^ *P* \< 0.05, ^∗∗^ *P* \< 0.01, ^∗∗∗^*P* \< 0.001 vs. Before.

Parameters were measured by boso ABI-system 100.

Parameters were measured by SphygmoCor device.

Effects of exercise and diet intervention on cardiac autonomic function
-----------------------------------------------------------------------

When focusing on the HRV indices of obese individuals at the baseline and at the end of 8 weeks of training program ([Table 3](#table-3){ref-type="table"}), we found a significant augmentation in levels of SDNN (47.74 ± 26.41 ms vs. 65.19 ± 24.52 ms, *P* \< 0.01) and RMSSD (39.43 ± 36.67 ms vs. 59.29 ± 37.61 ms, *P* \< 0.05) using time domain assessment. Moreover, we detected a significant improvement in frequency domain parameters (i.e., TP, LFnu, HFnu, and LF/HF; all *P* \< 0.05).
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###### The heart rate variability indices of subjects before and after 8-week combined exercise and diet intervention.

![](peerj-05-3900-g004)

  Parameters   Before          After
  ------------ --------------- ------------------
  SDNN (ms)    47.74 ± 26.41   65.19 ±24.52^∗∗^
  RMSSD (ms)   39.43 ± 36.67   59.29 ±37.61^∗^
  TP (ms^2^)   1672 ± 2467     3155 ±3298^∗^
  LFnu         55.45 ± 24.56   44.60 ±17.49^∗^
  HFnu         44.55 ± 24.56   55.40 ±17.49^∗^
  LF/HF        2.34 ± 2.52     1.06 ±0.92^∗^

**Notes.**

SDNNstandard deviation of normal-to-normal intervalsRMSSDsquare root of the mean squared differences of successive normal-to-normal intervalsTPtotal powerLFnulow-frequency power in normalized unitsHFnuhigh-frequency power in normalized unitsLF/HFlow-frequency power/high-frequency power

Values are presented as mean ± SD. ^∗^ *P* \< 0.05, ^∗∗^ *P* \< 0.01 vs. Before.

Correlations
------------

As shown in [Table 4](#table-4){ref-type="table"}, correlation analysis showed that the change in cfPWV was positively correlated with the change in LFnu (*r* = 0.516, *P* \< 0.05); however, changes in cfPWV were negatively correlated with changes in HFnu (*r* =  − 0.516, *P* \< 0.05). Both of the changes in cfPWV and right baPWV were positively associated with changes in LF/HF (*r* = 0.601, *P* \< 0.05 and *r* = 0.498, *P* \< 0.05, respectively). This suggests there is a significant correlation between reduced arterial stiffness and enhanced cardiac autonomic modulation following an exercise and diet intervention. The change in HR demonstrated a significant negative correlation with changes in HFnu (*r* =  − 0.587, *P* \< 0.05), SDNN (*r* =  − 0.618, *P* \< 0.05), and RMSSD (*r* =  − 0.643, *P* \< 0.05). In contrast, there was a positive correlation between changes in HR and LFnu (*r* = 0.587, *P* \< 0.05). We also found that changes in insulin resistance was positively correlated with changes in LFnu (*r* = 0.490, *P* \< 0.05) and negatively correlated with changes in HFnu (*r* =  − 0.490, *P* \< 0.05). Moreover, we observed a negative correlation between changes in hsCRP and both changes in TP and RMSSD (*r* =  − 0.777, *P* \< 0.01 and *r* =  − 0.738, *P* \< 0.01, respectively; [Table 4](#table-4){ref-type="table"}).

10.7717/peerj.3900/table-4

###### Associations of changes in heart rate variability indices with changes in pulse wave velocity, heart rate, insulin sensitivity and inflammatory pattern after 8-week combined exercise and diet intervention.

![](peerj-05-3900-g005)

          cfPWV                                      Right baPWV                               HR                                         HOMA-IR                                    hsCRP
  ------- ------------------------------------------ ----------------------------------------- ------------------------------------------ ------------------------------------------ --------------------------------------------
  TP      −0.101                                     −0.083                                    −0.286                                     −0.181                                     −0.777[^\*\*^](#table-4fn3){ref-type="fn"}
  LFnu    0.516[^\*^](#table-4fn2){ref-type="fn"}    0.327                                     0.587[^\*^](#table-4fn2){ref-type="fn"}    0.490[^\*^](#table-4fn2){ref-type="fn"}    0.290
  HFnu    −0.516[^\*^](#table-4fn2){ref-type="fn"}   −0.327                                    −0.587[^\*^](#table-4fn2){ref-type="fn"}   −0.490[^\*^](#table-4fn2){ref-type="fn"}   −0.290
  LF/HF   0.601[^\*^](#table-4fn2){ref-type="fn"}    0.498[^\*^](#table-4fn2){ref-type="fn"}   0.307                                      0.099                                      −0.063
  SDNN    −0.496                                     −0.269                                    −0.618[^\*^](#table-4fn2){ref-type="fn"}   −0.439                                     −0.149
  RMSSD   −0.366                                     −0.125                                    −0.643[^\*^](#table-4fn2){ref-type="fn"}   −0.392                                     −0.738[^\*\*^](#table-4fn3){ref-type="fn"}

**Notes.**

TPtotal powerLFnulow frequency in normalized unitsHFhigh frequency in normalized unitsLF/HFlow frequency/high frequencySDNNstandard deviation of normal-to-normal intervalsRMSSDsquare root of the mean squared differences of successive normal-to-normal intervalscfPWVcarotid-femoral pulse wave velocitybaPWVbrachial-ankle pulse wave velocityHRheart rateHOMA-IRHomeostasis Model of Assessment of Insulin ResistancehsCRPhigh-sensitivity C-reactive protein

*P* \< 0.05.

*P* \< 0.01.

Discussion
==========

The main findings of the current study were an observed improvement in cardiac autonomic activity by enhancing parasympathetic modulation and decreasing sympathetic modulation, correlated with a reduction in central and systemic arterial stiffness in people with obesity after an 8-week program consisting of exercise and dietary restriction.

Obesity is frequently accompanied by atherosclerotic plaque formation ([@ref-28]; [@ref-30]). Early prognosis of arterial stiffness can prevent obese people from suffering vascular disease. In the current study, we used two methods to measure cfPWV, and both methods detected a significant improvement in cfPWV after the intervention ([Table 2](#table-2){ref-type="table"}). The levels of baPWV may represent the dilation of the aorta and the lower-limb artery ([@ref-21]). High baPWV is closely correlated with weak arterial dilation, high stiffness, and poor elasticity. Evaluation of baPWV has become a new tool for measuring arterial stiffness because of its convenience and easy operation. In the current study, we found a significant reduction in right baPWV rather than left baPWV after the intervention, which suggests a location-specific effect of diet and exercise intervention on arterial stiffness. Moreover, we found that the change in baPWV was highly correlated with the change in cfPWV (*r* = 0.929, *P* \< 0.001), and this is in accordance with what has been elucidated previously ([@ref-31]). Therefore, it indicates that baPWV is a good method for use in studies measuring arterial stiffness because it has high reproducibility.

HRV is frequently decreased in patients with obesity or diabetes and is associated with a poor cardiovascular prognosis ([@ref-15]). Therefore, it is important to improve HRV in these patients with therapeutic approaches. To assess the overall autonomic activity, we used SDNN ([@ref-25]), and we found a significant increase in SDNN with enhanced overall parasympathetic activity demonstrated by RMSSD. This is consistent with a previous study in which a weight reduction program for children with obesity induced a change in autonomic activity toward parasympathetic dominance ([@ref-20]). Furthermore, our study revealed that TP, LFnu, HFnu, and LF/HF were significantly improved after the intervention. This suggests improved autonomic regulation by ways of increased parasympathetic modulation and decreased sympathetic modulation. A possible explanation for the HRV variations found in our study is that the exercise and diet intervention improved HR, insulin resistance, and inflammatory pattern, and these outcomes are important to the regulation of cardiac autonomic activity ([@ref-8]; [@ref-22]). Indeed, we observed a significant negative correlation between augmented HRV and the changes in these cardiovascular biomarkers ([Table 4](#table-4){ref-type="table"}). These results suggest the effects of an 8-week program of exercise and dietary restriction on cardiac autonomic modulation were partly due to the changes in these biomarkers.

A novel finding of our study was that a decreased sympathovagal balance (as assessed by LF/HF) was correlated with a reduction in PWV (i.e., cfPWV and baPWV) after an exercise and diet intervention. To the best of our knowledge, this is the first study to report a significant association between improved autonomic function and reduced vascular stiffness in both central and systemic vascular beds among obese adults undergoing lifestyle modifications of exercise and diet intervention. In accordance with our results, a previous study showed that 6 weeks of whole-body vibration training in young overweight and obese women reduced both baPWV and sympathovagal balance ([@ref-5]). The mechanisms underlying the association between changes in cardiac autonomic function and arterial stiffness after life modifications need to be elucidated in future studies.

A limitation of our current study is the lack of a control group during the training program of the intervention. Since the camp was located in a remote district of Huizhou city, China, and subjects enrolled in the program came from various locations across the country and had an average BMI over 35 kg/m^2^ (37.8 ± 5.0 kg/m^2^), the selection of an appropriate control group was restricted ([@ref-7]; [@ref-13]). Furthermore, we were limited by a small sample size. In future, we will also be interested in probing potential changes in central nervous system following exercise with diet intervention, such as using motor evoked potentials and its dynamic plasticity ([@ref-12]; [@ref-27]). These limitations are important and should be addressed in the future.

In conclusion, the present study found a correlation between an enhancement of cardiac autonomic function and a reduction in central and systemic arterial stiffness in obese adults after 8 weeks of exercise training with dietary restriction.
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